The stock was most recently helped by the company CEO’s optimism on its potential outside of COVID vaccines.

For some older adults, the flu vaccine could look a little different this year. In August, the US Food and Drug Administration approved the nation’s first mRNA-based flu vaccine for use in people 50 ...

The results, which triggered Moderna’s stock to drop, are “really encouraging,” says Karen Knudsen, CEO of the Parker ...

This article originally appeared on the Bloomberg School of Public Health website. An mRNA flu vaccine is on its way. On Aug. 5, the U.S. Food and Drug Administration approved Moderna's mFLUSIVA, the ...

Siladitya Ray is a New Delhi-based Forbes news team reporter. In a statement, vaccine maker Moderna said its “mFLUSIVA” vaccine against seasonal influenza has been approved for use by all adults aged ...

The U.S. Food and Drug Administration has approved a new flu vaccine, Moderna's mFlusiva, marking the public release of the first non-COVID-related mRNA vaccine in the U.S. Moderna's vaccine was ...

Severe sunburn increases the risk of developing melanoma, the most serious type of skin cancer. Credit: Olga Pankova/Getty. A ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...